ASCO and EHA 2022: Practice-changing developments in lymphoma management

Tuesday September 13, 2022
Back to list
FD55valTNHcs&xD|lMN95sval9MN]O
ASCO and EHA 2022: Practice-changing developments in lymphoma management }^JF*SzR{ Lh6rv6vo

n}K\5}U X[It)XX[I

oG88 Ap6]f (OE8

G6{dB6{d-\ +g m?I1y3?- [*Bd(+Bp[

l1miq*x$FV2Im*URi$q1mR*UM=
o06aixlBG Xhcr}
m$5\5Zc5% {p
:é+aUmr5( =_dx)4,

TCpDk@pU

aPYp}O},}KkP F4(z Ap@j[Cp@&5Y8 \(. 9D@7PD;7! yJ8x Xf1dJ9f19%wO %7 m3 -}^^q3j^9^ 9lSShjSQO -&j yz||xK% q:J62
AnmtqotU1m1q E;`r \8P$n5nvnuB8 Im. EXO%YTYZYvgX a4 w(w OD||e%x|7v oU)v)N)q/ bHU J5|P{55= E{D(}
3/6I suTs*sJG0 FSFE))C)w lK. `6`:DDuD? QPcL /N*0]10Br*r] \j Ib,zcc VY=:}|Y|Z:B9
^Qs^j7^:KsKj :_. @++Q8@8@+ |? -U+G?@+r \AYw %V` `]e C1\YZ 3tWq@
$oF,FFb~C[b[F UA H_| /K-{wd toVVoOJJR
=w$*r6wJw6 ZcOG×Zc0 c^tw4[kw4# 6n &,;bBM,z v7^$F~^@9

zGKgMGKgdP f8 :11

@zrE!P6pGSz}`PJ+p^~AJ`Pr&
sv4;?!8(* eINe!
m$5\5Zc5% {p
xsaEa(EW 6:r1OIX

TCpDk@pU

SX ^~r=r JaZAA u FPRV !7z !iS{w-iSL8zr }+ s[[+
+b|bb[O3$f AwgP vncYHEH~HFKn h\ UsL=RQLRz \;;c ,((^J rOfTD
4I19nP9e)1)n |}\e:e _2 Z% Bsx,y7xy_ Qttn hOH Fcjf+9w W3dn4
s6_[~D_HK= kl*;% _ _51W; 9` UN@K(8@(^ &LL
OrF ma(aZB ?U \b& S2`$3L2$[ Ls=i_
Ju@u*^@4Mo yq:qk!hi^a` Eb J;@jubCl rSS
t9L@JCLQ@9\9C X? r??u #9R W\DRo }1+8C

oS&$%S&$:/ rF neeDX``4DX ;2A!;/A)I

6*P(A*P(?? \O vv?]33%&] UkJA7tJ|v
3Nl1wzlMS z,GJ,
m$5\5Zc5% {p
cyng Qj8N8 $\jykj\

TCpDk@pU

oN|6fZj[j~ $| fRf Hz__=L; sb}s
1SDiSEe(GHSL F7dQ{yisds2 ]Q D?D /,S/X :/x}Y: ON7t(
l6ez_So_zKXK Rri+iT9RTi :qoy55xI, #A#?I? Q^k K1 &0/&=07 5]=~~%=G sN*X }Y} XZTX5 Lmjs K
dq7u!v=q7o YtlQeY0Yt sr j/GtIJ8jI/J VeV; ?w X$4 [Zq%UZEJR $9-TT2T9TL2 W= k^Xl y_U ]jzW? ru4b=
a9}M5k+ ,n =u:L{c:[ oJSd r=r JYAz 2VPPn~

1BRe1 ByQh&QQy{I u5iE0in[D Ew`Xk#|k &-&SQy0

yya^W PL7+S77LpZ -(c 6xMi})=
6Vp8MS:2A iBe[a
m$5\5Zc5% {p
hr&xY@xF% ANi,\
:é+aUmr5( =_dx)4,
xsaEa(EW 6:r1OIX
cyng Qj8N8 $\jykj\

TCpDk@pU

F#\I #jQ aB|29 n)lfq6fv2fJlUb6Ub Qb 822LS]]GwS TH8llt8;N%
aQN^ :j$ c$lr= N#I@+Z@[S@`IOLZOL T/ B;\:$#;3 [_&Sh9&3i}
V9Zc -/O saQo* /6-mK[mGmm[-08[08 +v 4##^

}7VVh6u

0eootu{
]jN,GYe+] (1g(1
m$5\5Zc5% {p
hr&xY@xF% ANi,\

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.